ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

1 1

Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets

Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets

As low as $299 each!
$349.00
$349.00
Sale Sold out
Shipping calculated at checkout.
  • FREE SHIPPING
  • 99%+ PURITY
  • MADE IN USA
View full details

What is Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets?

Brain Blend combines three research-focused compounds—Dihexa, Tesofensine, and BPC‑157—into a multidimensional investigational formulation aimed at studying neurotrophic support, neurotransmitter regulation, and regenerative processes: 

  • Dihexa is an oligopeptide derivative of angiotensin IV that binds with femtomolar affinity to hepatocyte growth factor (HGF), potentiating HGF/c-Met signaling. It has been shown in animal models to dramatically enhance synaptogenesis and cognitive performance—exhibiting potency orders of magnitude higher than BDNF in neurotrophic assays [1][2]. 
  • Tesofensine is a phenyltropane-based triple monoamine reuptake inhibitor (DAT, SERT, NET), initially researched for neurodegenerative conditions. It has significant impact on synaptic monoamine levels, which influences neuronal function and energy metabolism [3][4]. 
  • BPC‑157 is a 15–amino-acid peptide derived from human gastric juice, known in preclinical studies to promote angiogenesis, cytoprotective effects, and tissue regeneration via VEGF modulation and fibroblast activation [5][6]. 

This blend allows preclinical researchers to evaluate the combined effects of enhanced neurotrophic signaling, monoaminergic modulation, and tissue protection within neurobiological models. 

Chemical Structure of Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets

This section provides a brief chemical profile for each compound: 

  • Dihexa: Molecular formula C₂₇H₄₄N₄O₅, monoisotopic mass ~504. Results from PubChem and ChemSpider confirm its hexanoyl–Tyr–Ile–hexanoyl amide structure [1][7]. 
  • Tesofensine: Structured as (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane, with formula C₁₇H₂₃Cl₂NO and mass ~328 Da [3][8]. 
  • BPC‑157: Sequence Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Ala–Asp–Asp–Ala–Gly–Leu–Val; formula C₆₂H₉₈N₁₆O₂₂, monoisotopic mass ~1,419.5 Da [5][9]. 

What Are the Effects of Brain Blend - Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) x 60 Tablets?

Neurotrophic and Synaptogenic Activity:

Dihexa enhances HGF/c-Met signaling, promoting hippocampal synapse formation and cognitive function in rodent Alzheimer models—surpassing BDNF potency by several orders [2]. 

Monoamine Neurotransmission Modulation:

Tesofensine increases synaptic dopamine, norepinephrine, and serotonin. Preclinical research shows this elevates neuronal signaling tone and is associated with increased BDNF expression and neuroplasticity [3][4]. 

Angiogenic and Cytoprotective Actions:

BPC‑157 stimulates VEGF and FGF-2 pathways, enhancing vascular growth and fibroblast-driven tissue repair—and has shown protective effects in neural injury models [5][6]. 

Potential Enhanced Neuroregenerative Synergy:

By combining Dihexa’s synaptogenic and Tesofensine-driven neurotransmitter amplification with BPC‑157’s supportive tissue environment, this formulation enables investigation into synergistic pathways for brain regeneration and functional resilience. 

Citations

  1. NCATS Inxight Drugs – Dihexa potentiates HGF/c-Met activity; improves cognition and synapse formation in rat models.   
  2. PeptidesWiki: Dihexa binds HGF with high affinity, promotes synaptogenesis and cognitive improvement via c-Met signaling. 
  3. PubChem Compound Summary – Tesofensine (CID 11370864): triple monoamine reuptake inhibitor; formula C₁₇H₂₃Cl₂NO; MW ~328 Da. 
  4. ScienceDirect Topics – Tesofensine inhibits DAT, NET, SERT synaptic reuptake; increases monoaminergic signaling and BDNF expression in brain models. 
  5. PubChem Compound Summary – BPC‑157 (CID 9941957): pentadecapeptide; sequence and formula confirmed. 
  6. SciDirect Abstract – “The pentadecapeptide body protective compound (BPC157)… demonstrated an obvious protective effect on tissue” (tendon and neural models) [5]. 
  7. ChemSpider Record – Dihexa (CID 57582587) confirms molecular formula and structure. 
  8. ChemSpider Record – Tesofensine (CID 9545781), detailing molecular formula and structure. 
  9. DrugBank – BPC‑157 sequence and properties: Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Ala–Asp–Asp–Ala–Gly–Leu–Val; formula C₆₂H₉₈N₁₆O₂₂. 

COA

Certificate of Analysis

HPLC

High Performance Liquid Chromatography

High Quality - 99% Purity Guaranteed

Product Quality Guarantee

We are continuously conducting HPLC test on all of our raw powders as well as finished products to ensure the quality of our products. You can have the product you bought from us tested at any HPLC licensed testing facility and if the results are negative, we will refund the following:
HPLC TEST FEE
$100
PLUS Total amount of the Order + Shipping Fee

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)